Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial

References

Page 1

	Year	Citations
Emergence of an Extensively Drug-Resistant <i>Salmonella enterica</i> Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins Elizabeth J. Klemm, Sadia Shakoor, Andrew J. Page, mBio	2018	622
Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment Vittal Mogasale, Brian Maskery, R. Leon Ochiai, The Lancet Global Health Preventive MedicineRisk-factor AdjustmentHealth EconomicsEpidemiological OutcomeTyphoid Fever	2014	573
The Efficacy of a<i>Salmonella typhi</i>Vi Conjugate Vaccine in Two-to-Five-Year-Old Children Feng Lin, Vô Anh Hó, Ha Ba Khiem, New England Journal of Medicine	2001	470
The burden of typhoid fever in low- and middle-income countries: A meta-regression approach Marina Antillón, Joshua L. Warren, Forrest W. Crawford, PLoS neglected tropical diseases	2017	338
Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study Vineeth Varanasi, Anit Singh, Marcela F. Pasetti, Clinical Infectious Diseases	2015	199
Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal Mila Shakya, Rachel Colin-Jones, Katherine Theiss-Nyland, New England Journal of Medicine	2019	184
Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial Firdausi Qadri, Farhana Khanam, Xinxue Liu, The Lancet	2021	145
Undifferentiated Febrile Illness in Kathmandu, Nepal Corinne N. Thompson, Stuart D. Blacksell, Daniel H. Paris, American Journal of Tropical Medicine and Hygiene Typhoid FeverClinical Infectious DiseaseHealthcare-associated InfectionClinical EpidemiologyPediatrics	2015	99
Ceftriaxone-resistant<i>Salmonella</i>Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine Mohammad Tahir Yousafzai, Farah Naz Qamar, Sadia Shakoor, Clinical Infectious Diseases	2018	89
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study Joke Bilcke, Marina Antillón, Zoë Pieters, The Lancet Infectious Diseases	2019	81

Page 1